港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

同源康醫藥-B

14.180

-0.030-0.21%

成交量：300.88萬

成交額：4,286.04萬

市值：53.89億

市盈率：-11.35

高：14.400

開：14.350

低：14.110

收：14.210

52周最高：56.550

52周最低：13.000

股本：3.80億

香港流通股本：3.75億

量比：0.55

換手率：0.80%

股息：- -

股息率：- -

每股收益(LYR):-1.250

淨資產收益率：--

總資產收益率：-27.71%

市淨率：13.85

市盈率(LYR):-11.35

市銷率: 46194.08

資料載入中...

總覽公司新聞公告

同源康醫藥-B08月04日獲主力加倉10.9萬元

港股收評：8月迎開門黑！恒指跌1%，科指7連跌，創新藥熄火，三桶油下挫

同源康醫藥-B盤中異動早盤股價大跌5.02%

同源康醫藥-B盤中異動早盤股價大跌5.13%報21.250港元

每日沽空追蹤 | 同源康醫藥-B 07月30日沽空量成交3.15萬股，沽空比例為0.14%

同源康醫藥-B漲超3% 擬折讓19%配股淨籌約1.55億港元用於現有管線研發及商業化等

港股公告掘金 |華能國際電力股份上半年歸母淨利約92.62億元同比增長24.26%

每日沽空追蹤 | 同源康醫藥-B 07月29日沽空量成交2.05萬股，沽空比例為0.27%

同源康醫藥-B(02410.HK)擬折讓約19.00%配售923萬股配售股份淨籌約1.55億港元

同源康醫藥-B擬折讓約19.00%配售923萬股配售股份，淨籌約1.55億港元

同源康醫藥-B擬折讓19%配股總籌1.57億港元加碼研發與商業化佈局

同源康醫藥-B盤中異動下午盤急速拉昇5.16%

格隆匯個股放量排行榜 | 7月26日

同源康醫藥-B盤中異動早盤股價大漲5.00%

同源康醫藥-B(02410.HK)：TY-302、TY-2699a及TY-0540的I期臨牀試驗結果獲2025年歐洲腫瘤內科學會(ESMO)大會以壁報形式收錄

同源康醫藥-B(02410)：TY-302、TY-2699a及TY-0540的I期臨牀試驗結果獲2025年歐洲腫瘤內科學會(ESMO)大會以壁報形式收錄

同源康醫藥-B07月23日獲主力加倉467.5萬元

同源康醫藥(02410)CDK2/4抑制劑TY-00540為CDK4/6抑制劑耐藥後HR+/HER2-乳腺癌帶來新希望

港股異動 | 同源康醫藥-B(02410)尾盤急升逾7% 旗下三款創新藥研究成果獲ESMO 2025收錄

同源康醫藥(02410)三款創新藥研究成果獲2025年ESMO大會收錄

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02410/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康醫藥-B","latestPrice":14.18,"timestamp":1761293296003,"preClose":14.21,"halted":0,"volume":3008779,"delay":0,"floatShares":375457818,"shares":380065818,"eps":-1.2496898441295075,"marketStatus":"休市中","change":-0.03,"latestTime":"10-24 16:08:16","open":14.35,"high":14.4,"low":14.11,"amount":42860361,"amplitude":0.020408,"askPrice":14.18,"askSize":17000,"bidPrice":14.17,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.8416098300972005,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1761528600000},"marketStatusCode":7,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":14.21,"openAndCloseTimeList":[[1761269400000,1761278400000],[1761282000000,1761292800000]],"volumeRatio":0.5549935732963148,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-27.71%","roe":"--","lyrEps":-1.24969,"volumeRatio":0.5549935732963148,"shares":380065818,"dividePrice":0,"high":14.4,"amplitude":0.020408,"preClose":14.21,"low":14.11,"week52Low":13,"pbRate":"13.85","psRate":"46194.08","week52High":56.55,"institutionHeld":0,"latestPrice":14.18,"committee":-0.888889,"eps":-1.2496898441295075,"divideRate":0,"volume":3008779,"delay":0,"ttmEps":-0.8416098300972005,"open":14.35,"prevYearClose":47.15,"prevWeekClose":15.38,"prevMonthClose":16.54,"prevQuarterClose":16.54,"fiveDayClose":15.38,"twentyDayClose":15.7,"sixtyDayClose":22.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747411200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2025-10-23","current":-16.848663,"percent":0.742268,"low":-45.171338,"twenty":-25.404542,"median":-19.980609,"eighty":-16.774453,"high":-10.104382,"avg":-21.963571,"sd":6.395693,"marketCap":5400735273},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-23","current":-17.672452,"twenty":-25.404542,"median":-19.980609,"eighty":-16.774453,"marketCap":5400735273}],"updateTime":1761345941076},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556295800","title":"同源康醫藥-B08月04日獲主力加倉10.9萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556295800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556295800?lang=zh_tw&edition=fundamental","pubTime":"2025-08-04 16:15","pubTimestamp":1754295327,"startTime":"0","endTime":"0","summary":"08月04日，同源康医药-B股价收平报17.42元，成交金额5509.7万元，换手率0.86%，振幅4.42%，量比0.28。同源康医药-B今日主力资金净流入10.9万元，上一交易日主力净流入167.5万元。该股近5个交易日下跌17.14%，主力资金累计净流入372.7万元；近20日主力资金累计净流入1431.1万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804164811a6d1ff38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804164811a6d1ff38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1161","02410","BK1515"],"gpt_icon":0},{"id":"2556437898","title":"港股收評：8月迎開門黑！恒指跌1%，科指7連跌，創新藥熄火，三桶油下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2556437898","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556437898?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 16:20","pubTimestamp":1754036405,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["01024","ALBmain","159562","159938","JD","02359","NTES","MCHmain","09939","81024","HSCEI","TCEHY","600276","159992","METmain","01530","399441","HHImain","09999","03086","02410","161121","MIUmain","601857","09618","159582","TCHmain","01810","TTTN","603259","07226","01276","89618","HSTECH","06978","HSI","BABA","KSTmain","MPNGY","03690","BIDU","YANG","00700","HSImain","MHImain","02186","161726","01801"],"gpt_icon":0},{"id":"2556866577","title":"同源康醫藥-B盤中異動 早盤股價大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556866577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556866577?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 10:45","pubTimestamp":1754016336,"startTime":"0","endTime":"0","summary":"2025年08月01日早盘10时45分，同源康医药-B股票出现波动，股价快速下挫5.02%。截至发稿，该股报19.280港元/股，成交量244.55万股，换手率0.67%，振幅5.27%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.26%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801104536a6cccbc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801104536a6cccbc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2555074147","title":"同源康醫藥-B盤中異動 早盤股價大跌5.13%報21.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555074147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555074147?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 10:32","pubTimestamp":1753929145,"startTime":"0","endTime":"0","summary":"2025年07月31日早盘10时32分，同源康医药-B股票出现波动，股价急速下挫5.13%。截至发稿，该股报21.250港元/股，成交量248.5万股，换手率0.68%，振幅6.25%。资金方面，该股资金流入1022.35万港元，流出3417.18万港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.10%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073110322594c51a0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073110322594c51a0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","09939","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2555452390","title":"每日沽空追蹤 | 同源康醫藥-B 07月30日沽空量成交3.15萬股，沽空比例為0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555452390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555452390?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 16:30","pubTimestamp":1753864233,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间07月30日，涨4.92%，卖空量成交3.15万股%，较上一交易日增加53.66%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172146a6c97120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730172146a6c97120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02410","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"2555096923","title":"同源康醫藥-B漲超3% 擬折讓19%配股淨籌約1.55億港元 用於現有管線研發及商業化等","url":"https://stock-news.laohu8.com/highlight/detail?id=2555096923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555096923?lang=zh_tw&edition=fundamental","pubTime":"2025-07-30 10:04","pubTimestamp":1753841069,"startTime":"0","endTime":"0","summary":"同源康医药-b涨超3%，截至发稿，涨2.34%，报21.85港元，成交额3234.21万港元。消息面上，同源康医药-b发布公告，于2025年7月28日，公司与配售代理订立配售协议，据此，配售代理有条件同意作为公司的配售代理，按尽力基准促使承配人按每股配售股份17.01港元的配售价购买923万股配售股份。假设所有配售股份获悉数配售及待完成后，预期配售事项所得款项总额及所得款项净额将分别约为1.57亿港元及1.55亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102647a6c8c6c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730102647a6c8c6c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1515","02410","BK1161"],"gpt_icon":0},{"id":"2555605080","title":"港股公告掘金 |華能國際電力股份上半年歸母淨利約92.62億元 同比增長24.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555605080","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555605080?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 23:13","pubTimestamp":1753802009,"startTime":"0","endTime":"0","summary":"【重大事项】创梦天地(01119)及深圳创梦与PLR Worldwide Sales Limited订立资本化协议同源康医药-B(02410)拟折让约19.00%配售923万股配售股份 净筹约1.55亿港元盛业(06069)设立新加坡国际总部及探索Web3.0生态和稳定币创新应用场景康宁杰瑞制药-B(09966)：JSKN003获美国FDA授予用于治疗GC/GEJ的孤儿药资格认定上海医药(0260","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","BK1529","BK1530","HSCEI","BK1613","00902","YANG","BK1125","06069","HSTECH","BK1149","00763","BK1506","01901","BK1618","BK1161","BK1164","BK1526","BK1586","BK4614","BK1186","BK1607","BK1609"],"gpt_icon":1},{"id":"2555051014","title":"每日沽空追蹤 | 同源康醫藥-B 07月29日沽空量成交2.05萬股，沽空比例為0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555051014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555051014?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 16:30","pubTimestamp":1753777828,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间07月29日，涨1.67%，卖空量成交2.05万股%，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729171939a4696045&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729171939a4696045&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","02410","BK1574","BK1161"],"gpt_icon":0},{"id":"2555970263","title":"同源康醫藥-B(02410.HK)擬折讓約19.00%配售923萬股配售股份 淨籌約1.55億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555970263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555970263?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 07:02","pubTimestamp":1753743747,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","159938","02410","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"2555702652","title":"同源康醫藥-B擬折讓約19.00%配售923萬股配售股份，淨籌約1.55億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555702652","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555702652?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 07:02","pubTimestamp":1753743747,"startTime":"0","endTime":"0","summary":"假设于本公告日期至交割日期期间已发行股份数目并无变动，则配售事项项下的923万股配售股份相当于经配发及发行配售股份扩大后的已发行H股数目的约2.46 %及已发行股份数目的约2.43%。假设所有配售股份获悉数配售及待完成后，预期配售事项所得款项总额及所得款项净额将分别约为1.57亿港元及1.55亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","02410","159938","09939","BK1161","BK1574"],"gpt_icon":1},{"id":"2555076704","title":"同源康醫藥-B擬折讓19%配股總籌1.57億港元 加碼研發與商業化佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2555076704","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555076704?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 06:38","pubTimestamp":1753742305,"startTime":"0","endTime":"0","summary":"格隆汇7月29日丨同源康医药-B发布公告，2025年7月28日，公司与配售代理订立配售协议，据此，配售代理有条件同意作为公司的配售代理，按尽力基准促使承配人按每股配售股份17.01港元的配售价购买923万股配售股份。预期配售代理将促使不少于6名承配人认购配售股份。假设所有配售股份获悉数配售及待完成后，预期配售事项最高所得款项总额及所得款项净额将分别约为1.57亿港元及1.55亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072906383994c01a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072906383994c01a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","02410","BK1574","BK1515"],"gpt_icon":1},{"id":"2554251347","title":"同源康醫藥-B盤中異動 下午盤急速拉昇5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554251347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554251347?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 14:56","pubTimestamp":1753685802,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘14时56分，同源康医药-B股票出现波动，股价急速上涨5.16%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。同源康医药-B股票所在的生物技术行业中，整体涨幅为2.34%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281456429722a7aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281456429722a7aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1574","09939","BK1515","BK1161"],"gpt_icon":0},{"id":"2554161997","title":"格隆匯個股放量排行榜 | 7月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2554161997","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554161997?lang=zh_tw&edition=fundamental","pubTime":"2025-07-26 17:30","pubTimestamp":1753522203,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日中国光大绿色环保(01257)、中国国航(00753)、互太纺织(01382)、微创医疗(00853)、重庆农村商业银行(03618)、广联科技控股(02531)、华虹半导体(01347)、光大环境(00257)、滨江服务(03316)、嘉鼎国际集团(08153)、元续科技(08637)、万顺瑞强集团(08427)、天德化工(00609)、基石科技控股(08391)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/26173052004150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01799","09901","01257","08637","02628","01776","03993","01223","03833","01361","09666","03836","02209","03996","08299","00023","01618","01258","06818","03938","09658","00038","00358","08635","02600","00384","00363","08153","01030","02419","09979","03931","00017","09896","09699","02068","02175","02057","02338","09676","01733","06881","00670","02689","01760","01525","02410","01252","02380"],"gpt_icon":1},{"id":"2554732832","title":"同源康醫藥-B盤中異動 早盤股價大漲5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554732832?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 09:32","pubTimestamp":1753407161,"startTime":"0","endTime":"0","summary":"2025年07月25日早盘09时32分，同源康医药-B股票出现波动，股价快速拉升5.00%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，维立志博-B、中国抗体-B、奥星生命科技涨幅较大，振幅较大的相关个股有维立志博-B、奥星生命科技、北海康成-B，振幅分别为21.00%、8.89%、5.33%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509324194b96701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509324194b96701&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","02410","BK1161","BK1515"],"gpt_icon":0},{"id":"2553789679","title":"同源康醫藥-B(02410.HK)：TY-302、TY-2699a及TY-0540的I期臨牀試驗結果獲2025年歐洲腫瘤內科學會(ESMO)大會以壁報形式收錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2553789679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553789679?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 22:51","pubTimestamp":1753368686,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02410","09939","BK1583","BK1576","BK1515","03347","BK1161","BK1574","159938","TY","BK1141"],"gpt_icon":0},{"id":"2553678967","title":"同源康醫藥-B(02410)：TY-302、TY-2699a及TY-0540的I期臨牀試驗結果獲2025年歐洲腫瘤內科學會(ESMO)大會以壁報形式收錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2553678967","media":"智通财经","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553678967?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 22:51","pubTimestamp":1753368686,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，公司自主研发的三款临床产品TY-302、 TY-2699a及TY-0540的I期临床试验结果，正式获2025年欧洲肿瘤内科学会 大会以壁报形式收录。初步临床数据显示，TY-2699a在同类剂量水平下兼具优异安全性和初步疗效。TY-0540是一种选择性CDK2抑制剂，拟用于治疗乳腺癌、卵巢癌及前列腺癌等其他实体瘤。欧洲肿瘤内科学会成立于1975年，是全球领先的肿瘤学专业学术组织。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","159938","BK1161","BK1141","09939","TY","BK1574","BK1583","02410","03347","BK1576"],"gpt_icon":0},{"id":"2553921319","title":"同源康醫藥-B07月23日獲主力加倉467.5萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553921319","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553921319?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 16:15","pubTimestamp":1753258558,"startTime":"0","endTime":"0","summary":"07月23日, 同源康医药-B股价涨2.83%，报收19.64元，成交金额8716.9万元，换手率1.22%，振幅7.80%，量比1.55。同源康医药-B今日主力资金净流入467.5万元，上一交易日主力净流入88.1万元。该股近5个交易日上涨3.74%，主力资金累计净流入403.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1898.1万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170417a6bcef56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170417a6bcef56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1161","02410","BK1515"],"gpt_icon":0},{"id":"2553931212","title":"同源康醫藥(02410)CDK2/4抑制劑TY-00540為CDK4/6抑制劑耐藥後HR+/HER2-乳腺癌帶來新希望","url":"https://stock-news.laohu8.com/highlight/detail?id=2553931212","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553931212?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 11:29","pubTimestamp":1753241391,"startTime":"0","endTime":"0","summary":"同源康TY-00540：全球领先的CDK2/4双靶点抑制剂，靶向耐药关键机制CDK4/6抑制剂耐药的核心机制之一，是肿瘤细胞通过上调CDK2活性绕过CDK4/6抑制，驱动细胞周期持续进展。TY-00540通过同时抑制CDK4/6和CDK2双重阻断肿瘤细胞周期进程，从而克服CDK4/6抑制剂耐药。综上，TY-00540的药物研发处于世界领先位置，将有望填补HR+/HER2-乳腺癌CDK4/6耐药后无有效药物可用的空白。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1227","BK1574","BK1161","09939","00540","BK0187","BK4225","BK0188","159938","BK0012","HR","TY","02410","BK0183","BK0028","000876","BK4203","BK0196","BK0238"],"gpt_icon":0},{"id":"2553238896","title":"港股異動 | 同源康醫藥-B(02410)尾盤急升逾7% 旗下三款創新藥研究成果獲ESMO 2025收錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2553238896","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553238896?lang=zh_tw&edition=fundamental","pubTime":"2025-07-22 15:49","pubTimestamp":1753170580,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B尾盘急升逾7%，截至发稿，涨5.53%，报19.08港元，成交额6276.81万港元。消息面上，同源康医药今日宣布，公司自主研发的三款创新药物——CDK2/4抑制剂TY-00540、CDK7抑制剂TY-2699a及CDK4/6抑制剂TY-302的I期临床试验结果，正式获2025年欧洲肿瘤内科学会大会以壁报形式收录。此外，同源康医药6月9日正式获纳入恒生生物科技指数成份股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02410","09939","BK1574","159992","BK1515","06978","159938"],"gpt_icon":0},{"id":"2553282554","title":"同源康醫藥(02410)三款創新藥研究成果獲2025年ESMO大會收錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2553282554","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553282554?lang=zh_tw&edition=fundamental","pubTime":"2025-07-22 14:28","pubTimestamp":1753165739,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药今日宣布，公司自主研发的三款创新药物——CDK2/4抑制剂TY-00540、CDK7抑制剂TY-2699a及CDK4/6抑制剂TY-302的I期临床试验结果，正式获2025年欧洲肿瘤内科学会大会以壁报形式收录。潜在\"同类最佳\"CDK7抑制剂TY-2699a彰显治疗优势TY-2699a是同源康医药开发的新一代CDK7抑制剂，在25种CDK家族激酶筛选中展现出对CDK7的高度选择性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","BK1161","BK1515","02410","09939","BK1574","159938","06978"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":145,"code":"91000000","status":"200"}]}}